- Home
- AAL vs CORT Comparison
AAL vs CORT Comparison
Compare AAL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAL
- CORT
- Stock Information
- Founded
- AAL 1930
- CORT 1998
- Country
- AAL United States
- CORT United States
- Employees
- AAL N/A
- CORT N/A
- Industry
- AAL Air Freight/Delivery Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AAL Consumer Discretionary
- CORT Health Care
- Exchange
- AAL Nasdaq
- CORT Nasdaq
- Market Cap
- AAL 8.7B
- CORT 7.6B
- IPO Year
- AAL N/A
- CORT N/A
- Fundamental
- Price
- AAL $12.53
- CORT $69.53
- Analyst Decision
- AAL Hold
- CORT Strong Buy
- Analyst Count
- AAL 14
- CORT 4
- Target Price
- AAL $14.46
- CORT $139.00
- AVG Volume (30 Days)
- AAL 75.0M
- CORT 644.6K
- Earning Date
- AAL 10-23-2025
- CORT 10-29-2025
- Dividend Yield
- AAL N/A
- CORT N/A
- EPS Growth
- AAL N/A
- CORT N/A
- EPS
- AAL 0.86
- CORT 1.11
- Revenue
- AAL $54,250,000,000.00
- CORT $716,080,000.00
- Revenue This Year
- AAL $1.39
- CORT $30.62
- Revenue Next Year
- AAL $6.15
- CORT $37.68
- P/E Ratio
- AAL $14.55
- CORT $62.97
- Revenue Growth
- AAL 1.50
- CORT 25.71
- 52 Week Low
- AAL $8.50
- CORT $37.82
- 52 Week High
- AAL $19.10
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- AAL 45.87
- CORT 45.26
- Support Level
- AAL $12.61
- CORT $67.32
- Resistance Level
- AAL $13.23
- CORT $74.79
- Average True Range (ATR)
- AAL 0.43
- CORT 2.36
- MACD
- AAL -0.11
- CORT 0.14
- Stochastic Oscillator
- AAL 3.27
- CORT 29.58
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.